Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Quality of this NR is so much better

<< Previous

Bullboard Posts

Next >>

Comment by reconsideron Aug 12, 2024 10:54am

231 Views

Post# 36174449

RE:RE:RE:RE:Quality of this NR is so much better

II see this a good, serious release.
Goals still in Q3 and explanation on why the last delay (Post Study II Monitoring of Response and Central Pathology Laboratory Review).
I believe that after the warrants expire we will see a SP climb in September-October. Still a chance that in the next couple of weeks we touch 9 cents... good news we already did today :)
Optimistic about Q4.
GLTA

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles